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INTRODUCTION 
Polycystic ovary syndrome (PCOS)  is a common endocrine system disorder  
among women of reproductive age.[1]Metabolic derangements and associated 
complications include insulin resistance and diabetes, hyperlipidemia, hypertension, 
fatty liver, metabolic syndrome and sleep apnea.[2] Polycystic ovary syndrome 
(PCOS) is a common condition characterized by menstrual abnormalities and clinical 
or biochemical features of hyperandrogenism, altered    LH: FSH ratio (>2/3:1).[3] 
Features of PCOS may manifest at any age, ranging from childhood (premature 
puberty), teenage years (hirsutism, menstrual abnormalities), early adulthood and 
middle life (infertility, glucose intolerance) to later life (diabetes mellitus and 
cardiovascular disease.[4-6] 
  
PCOS is now recognised to be a metabolic syndrome which may include 
hyperinsulinaemia, hyperlipidaemia, diabetes mellitus, and possibly cardiac disease, 
as well as the more conventionally recognised increase in androgen levels, cosmetic 
problems, anovulation, infertility, endometrial cancer and obesity.[7,8] PCOS is 
estimated to affect between 5 and 10 percent of women of reproductive age, affects 
women of all races and nationalities. Women with PCOS may have enlarged ovaries 
that contain small collections of fluid called follicles located in each ovary. Polycystic 
means the ovaries have many cysts or follicles that rarely grow to maturity or produce 
eggs capable of being fertilized.The presence of polycystic ovaries on ultrasound 
examination is particularly controversial as a criterion. Polycystic ovaries are 
characterised by peripheral cysts (10 or more) less than 10mm in size in an enlarged 
ovary with significant increase in the central stroma.[9] 
PCOS is a set of symptoms that result from a hormonal imbalance affecting 
women and girls of childbearing age. Infrequent or prolonged menstrual periods, 
excess hair growth, acne, and obesity can all occur in women with polycystic ovary 
syndrome. A condition in which women have high levels of male hormones, 
increasing the risk of irregular or absent menstrual cycles, infertility, obesity, Women 
with PCOS usually have at least two of the following three conditions: 
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Fig.1: Poly Cystic Ovary Syndrome 
• Absence of ovulation, leading to irregular menstrual periods or no periods at 
all 
• High levels of androgens (a type of hormone) or signs of high androgens, such 
as having excess body or facial hair 
• Cysts (fluid-filled sacs) on one or both ovaries—"polycystic" literally means 
"having many cysts. 
         In addition, women with PCOS display reduced health-related quality of  life as 
well as symptoms of anxiety and depression [10,11]. 
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Epidemiology  
 
 Several studies have suggested a prevalence of PCOS of 5%– 10% in women 
of reproductive age, using the diagnostic criteria of the US National Institutes of 
Health.[12,13] Polycystic ovaries alone were found in 20%–25% of women in surveys in 
the United Kingdom and New Zealand.[14,15] While women with polycystic ovaries 
and no evidence of menstrual dysfunction or hyperandrogenism appear normal, they 
do have an overexaggerated response to stimulation with gonadotrophins such as 
follicle-stimulating hormone (FSH) in cycles of assisted reproduction. PCOS is 
generally underdiagnosed, and clinicians should remember that menstrual 
abnormalities, such as cycles shorter than 21 days or longer than 35 days, are often 
associated with the condition. Many young women with these abnormalities are 
prescribed the oral contraceptive pill, which masks the condition until they try to 
achieve pregnancy.[16] 
 
Pathogenesis 
 The pathogenesis of PCOS is poorly understood, but the primary defect may 
be insulin resistance leading to hyperinsulinaemia. In the ovary, the cardinal feature is 
functional hyperandrogenism. Circulating concentrations of insulin and luteinising 
hormone (LH) are generally raised. The theca cells, which envelop the follicle and 
produce androgens for conversion in the ovary to oestrogen, are over responsive to 
this stimulation. They increase in size and overproduce androgens. The rise in LH 
levels is thought to be caused by the relatively high and unchanging concentrations of 
oestrogens that may alter the control of this hormone by the hypothalamic–pituitary 
axis. This combination of raised levels of androgens, oestrogen, insulin and LH 
explains the classic PCOS presentation of hirsutism, anovulation or dysfunctional 
bleeding, and dysfunction of glucose metabolism. Paradoxically, although the insulin 
regulatory molecules on the theca cells are responsive to insulin those in the muscle 
and liver are resistant.[17] Dysregulation of cytochrome p450c17, the androgen-
forming enzyme in both the adrenals and the ovaries, may be the central pathogenic 
mechanism underlying hyperandrogenism in PCOS. In the presence of 5-alpha-
reductase, testosterone is converted within the cell to the more potent androgen 
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dihydrotestosterone. Excess 5-alphareductase activity in the skin determines the 
presence or absence of hirsutism.[18] 
 
Fig 2.Pathophysiology of polycystic ovary syndrome 
Etiology of PCOS 
 PCOS is a hormonal condition commonly involving high levels of insulin or 
male hormones known as ‘androgens’, or both.  PCOS is caused by an imbalance in 
the hormones (chemical messengers) in brain and ovaries. PCOS develops when the 
ovaries overproduce androgens (e.g., testosterone). Androgen overproduction often 
results from overproduction of LH (luteinizing hormone) by pituitary gland which 
results in extra testosterone production by the ovary. 
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Fig.3 Etiology of Poly Cystic Ovary Syndrome 
1. The pituitary gland in your brain makes the hormones luteinizing hormone (LH) 
and follicle stimulating hormone (FSH). 
2. After getting the signal from the hormones LH and FSH, the ovaries make estrogen 
and progesterone the female sex hormones. 
3. All normal ovaries also make a little bit of the androgen testosterone a male sex 
hormone. The pancreas is an organ that makes insulin. High levels of insulin can also 
cause the ovaries to make more of the hormone testosterone. 
The exact cause of polycystic ovary syndrome (PCOS) is unknown, but it’s thought to 
be related to abnormal hormone levels. 
Resistance to insulin 
Insulin is a hormone produced by the pancreas to control the amount of sugar in the 
blood. It helps move glucose from blood into cells, where it is broken down to 
produce energy. 
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Insulin resistance means the body’s tissues are resistant to the effects of insulin. The 
body therefore has to produce extra insulin to compensate. 
High levels of insulin cause the ovaries to produce too much testosterone hormone, 
which interferes with the development of the follicles (the sacs in the ovaries where 
eggs develop) and prevents normal ovulation. 
Insulin resistance can also lead to weight gain, which can make PCOS symptoms 
worse because having excess fat causes the body to produce even more insulin.[19] 
Hormone imbalance 
 
Fig.  4. Hormonal imbalance during PCOS 
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Many women with PCOS are found to have an imbalance in certain hormones, 
including: 
➲ Raised levels of testosterone - a hormone often thought of as a male hormone, 
although all women normally produce small amount of it. 
➲ Raised levels of luteinizing hormone (LH) – a hormone that stimulates ovulation, 
but may have an abnormal effect on the ovaries if levels are too high. 
➲ Low levels of sex hormone binding globulin (SHBG) – a hormone that helps 
reduce the effect of testosterone. 
➲ Raised levels of prolactin (only in some women with PCOS) – a hormone that 
stimulates the breast glands to produce milk in pregnancy. 
The exact reason why these hormonal changes occur is not known. It’s been 
suggested that the problem may start in the ovary itself, in other glands that produce 
these hormones, or part of the brain that controls their production. The changes may 
also be caused by the resistance to insulin.[20] 
Causes of PCOS 
Following are few important causes [21] of PCOS: 
1) Genetic predisposition 
2) Strong stimulation in adrenals in childhood 
3) Raised insulin levels 
4) Contraceptive pills 
5) Hormonal imbalance 
6) Stress 
PCOS and age 
More and more evidences indicate that PCOS appears to be a pathology that 
involves “the whole” life of the woman, that begins in the intra uterine life in 
genetically predisposed individuals, occurs at the time of puberty, endures in child 
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bearing age and exposes, especially after menopause, to a higher risk of developing 
endometrial cancer, cardiovascular disease, hypertension, diabetes mellitus type 2. 
For these reasons it is clear that a correct and early diagnosis of this syndrome is 
fundamental, as it allows to perform the most appropriate treatments and check-ups 
thus reducing the risk of developing all the complications related to it. 
 
Symptoms of polycystic ovarian syndrome: 
 
Women who have PCOS [22] may experience:  
• irregular menstrual cycles – menstruation may be less or more frequent due to 
less frequent ovulation (production of an egg)  
• amenorrhoea (no periods) – some women with PCOS do not menstruate, in 
some cases for many years  
• Hirsutism (excessive hair growth on the face, chest, abdomen, etc.) possibly 
due to increased free testosterone 
• Hair loss (androgenic alopecia, in a classic "male baldness" pattern) 
• Acne 
• Polycystic ovaries 
• Obesity 
• Infertility or reduced fertility 
• mood changes – including anxiety and depression  
 In addition, women with PCOS appear to be at increased risk of developing 
the following health problems during their lives: 
• Insulin resistance 
• Diabetes 
• Lipid abnormalities 
• Obstructive sleep apnea 
• Cardiovascular disease 
• Endometrial carcinoma (cancer) 
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Manifestations of PCOS 
PCOS is a lifelong condition which may have effects at all ages, not just in the 
reproductive years. 
 
Fetal life 
The condition may have its origins in fetal life, with either intrauterine growth 
retardation or post-term birth. Researchers have claimed that these children are more 
prone to hyperinsulinism, premature pubarche and signs of PCOS early in 
reproductive life.[23,24] 
 
Teenagers will often have oligo- or amenorrhoea, hirsutism, acne and weight 
disorders. It is controversial whether patients with PCOS suffer from a raised 
prevalence of bulimia.  
 
Women seeking to become pregnant will have difficulties because of anovulation 
and later may be concerned about overweight and hirsutism. It is controversial 
whether miscarriage is increased in PCOS, or whether pregnancy loss is a result of 
excess body weight. 
 
Diagnosis of PCOS 
 The diagnostic criteria for PCOS are controversial but diagnosis is generally 
based on peripubertal onset of menstrual problems with clinical or biochemical 
hyperandrogenism. Polycystic ovaries are characterised by peripheral cysts (10 or 
more) less than 10mm in size in an enlarged ovary with significant increase in the 
central stroma.[25] Polycystic ovaries are also found in women with no evidence of 
menstrual dysfunction or hyperandrogenism.[26,27] 
Diagnosis of PCOS  is now largely based on the Rotterdam criteria which are 
inclusive of the original National Institutes of Health (NIH) criteria15 and require two 
of three key features: oligo- or anovulation, clinical and/or biochemical hyper 
androgenism and polycystic ovaries . However, as noted, PCOS phenotypes vary 
widely depending on life stage, genotype, ethnicity and environmental factors, 
including lifestyle and body weight. 
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Fig.5. Diagnosis of PCOS 
Diagnosis of PCOS is likely to involve:  
• Medical history  
• Ultrasound, to assess whether ovaries are enlarged and cystic. 
• Blood tests, to detect elevated levels of androgens. 
• Blood test to detect high levels of LH (luteinizing hormone) or an elevation in the 
ratio of LH to FSH (follicle stimulating hormone). 
• Monitoring of the ovary's response to either a stimulatory dose of gonadotropin-
releasing hormone agonist  
Early diagnosis is important as it can allow symptoms to be managed and may prevent 
the development of long-term health problems such as diabetes. 
Diagnostic investigations must exclude other causes and include thyroid function tests 
and prolactin and follicle stimulating hormone (FSH) levels.[28] 
 
 
 
 
                                                                                                                 Introduction 
 
 
 11 
 
PCOS AND THE METABOLIC SYNDROME 
 Features of the metabolic syndrome, including obesity, insulin resistance and 
dyslipidaemia, are common in women with PCOS. 
 
 
 
Fig.6. PCOS and the metabolic syndrome 
 
OBESITY: 
The incidence of obesity in women with PCOS varies between countries and 
ethnic groups. In the United States, about 50% of women with PCOS are overweight 
or obese, but this prevalence differs little from that in the, general community. In 
other countries, PCOS appears to be associated with obesity, but at a lower rate than 
in the US. Obesity tends to be central (abdominal) in its distribution, and even lean 
women with PCOS may have a fat distribution favouring central omentaland visceral 
fat. 
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INSULIN RESISTANCE:  
This is independently related to PCOS, with women of normal weight with 
PCOS showing a degree of hyperinsulinaemia and impaired glucose disposal after 
meals and during glucose tolerance tests (oral or intravenous).[29] It is uncertain 
whether this insulin resistance results from a specific genetic post-receptor defect, 
such as a defect in serine phosphorylation,[30] or whether it is comparable to the 
problem seen in type 2 diabetes. Certainly, hyperinsulinism is common but is difficult 
to interpret clinically, given the fact that it also results from obesity. 
 
 
Fig.7.Insulin resistance and PCOS 
 
IMPAIRED GLUCOSE TOLERANCE AND TYPE 2 DIABETES:  
`These are major complications in overweight women with PCOS. While 
fasting glucose level is usually normal, insulin release after a glucose load is 
increased, and glucose disposal is impaired. An excellent epidemiological study in the 
UK that followed up women with a histological diagnosis of PCOS after wedge 
resection of the ovaries found clear evidence of an increase in the rate of diabetes.[31] 
This confirmed the results of many other studies from the US and Europe. In obese  
 
                                                                                                                 Introduction 
 
 
 13 
 
women with PCOS, progression from normal glucose function to impaired glucose 
tolerance or diabetes mellitus is more rapid than in women without PCOS.[32] 
 
DYSLIPIDAEMIA:  
Hypertriglyceridaemia, increased concentrations of low-density lipoprotein 
(LDL) cholesterol and decreased concentrations of high-density lipoprotein (HDL) 
cholesterol are common in women with PCOS, particularly if obese. Levels of 
plasminogen activator inhibitor-1 may also be raised, suggesting a chronic underlying 
inflammatory- like process 
 
CARDIOVASCULAR DISEASE:  
The metabolic features of PCOS have led to widespread concern about the risk 
of cardiovascular disease. A higher than expected prevalence of PCOS has been 
reported among young women with angiographically proven narrowing of the 
coronary vessels; women with PCOS were also more likely to have sonographic 
evidence of premature obstruction of other large vessels.[33,34] However, a UK study of 
medical records and death certificates of women with a histological diagnosis of 
PCOS revealed no evidence for an increase in myocardial infarction or other types of 
heart disease. 
Fig.8.Cardiometabolic risk assessment in PCOS 
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TREATMENTS AND DRUGS 
Polycystic ovary syndrome treatment generally focuses on management on 
main concerns, such as infertility, hirsutism, acne or obesity. Regular exercise, a diet, 
weight control, and not smoking are all important parts of treatment for polycystic 
ovary syndrome (PCOS) There is no cure for PCOS, but controlling it lowers your 
risks of infertility, miscarriages, diabetes, heart disease, and uterine cancer. 
 
 
 
 
MANAGEMENT 
Management comprises treatment of the presenting symptoms, as well as any 
other abnormalities discovered on investigation. Depending on the problems, 
management of PCOS can include lifestyle modifications, weight reduction, and 
treatment with hormones or medications. The modality depends on the desire for 
fertility Research has shown that even a five to 10 per cent loss of weight in those 
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who are overweight can restore normal hormone production and helps regulate 
periods and improve fertility. 
 
Hirsutism 
Hirsutismshould be assessed qualitatively or semiquantified using the 
FerrimanGallwey score.[35] 
 
Treatment may include: 
 The oral contraceptive pill (eg, ethinyloestradiol 35 µg plus cyproterone 
acetate 2mg daily for 21 of 28 days); 
 Cosmetic measures (eg, laser electrolysis, bleaching, waxing or shaving) 
 Oraloestrogen and cyproterone acetate (oestradiolvalerate 2mg daily and 
cyproterone acetate 50 mg for 14 days a month); 
 Spironolactone (75–200mg daily); or 
 Other drugs, such as the antiandrogenflutamide or the antifungal agent 
ketoconazole. These drugs either reduce androgen production or inhibit 
androgen-binding to the receptor. They are not in general use for this purpose 
in Australia. Response times for drugs can be up to 3 months. 
 
 
Fig. 9. Women with hirsutism 
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MENSTRUAL DYSFUNCTION AND ENDOMETRIAL HYPERPLASIA 
Menstrual Dysfunction, including irregular periods, can be managed by 
administration of progestins (eg, medroxyprogesterone acetate or norethisterone) or 
the oral contraceptive pill. 
 
Fig.10.Hypothalamic-Pituitary-Ovarian Dysfunction in PCOS 
 
Endometrial Hyperplasia should be assessed by ultrasound examination, 
endometrial biopsy or hysteroscopy, and can be treated by hormonal therapy, such as 
the oral contraceptive pill or progestins. 
Comparison of Regular Menstrual Cycle with PCOS Cycle 
1.The menstrual cycle starts when the brain sends LH and FSH to the ovaries. A big 
surge of LH is the signal that causes the ovaries to ovulate, or release an egg. 
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2.The egg travels down the fallopian tube and into the uterus. Progesterone from the 
ovary causes the lining of the uterus to thicken. 
3.If the egg isn’t fertilized, the lining of the uterus is shed. This is a menstrual period. 
4. After the menstrual period, the cycle begins all over again. 
 
Fig.11.Comparition of Normal and PCOS Menstrual Cycle 
The most common form of treatment for PCOS is the birth control pill; however, 
other kinds of hormonal therapy may include the “vaginal ring” and “the patch”. Even 
if you’re not sexually active, birth control pills may be prescribed because they 
contain the hormones that your body needs to treat your PCOS. By taking the birth 
control pill either continuously or in cycles you can: 
• Correct the hormone imbalance 
• Lower the level of testosterone (which will improve acne and lessen hair 
growth) 
• Regulate your menstrual periods 
• Lower the risk of endometrial cancer (which is slightly higher in young 
women who don’t ovulate regularly) 
• Prevent an unplanned pregnancy if you are sexually active 
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OVERWEIGHT, OBESITY AND GLUCOSE INTOLERANCE 
Lifestyle changes are a first-line intervention in women with PCOS who are 
overweight.[36] Glucose intolerance can be managed by diet and exercise, weight 
control and oral antidiabetic drugs (eg, metformin). 
 
INFERTILITY 
The cause of infertility in patients with PCOS is generally lack of ovulation 
because of a failure of the follicles to develop beyond 10mm. Most cycles are 
anovulatory, and induction of ovulation is essential. 
 
LIFESTYLE MODIFICATION:  
Several studies have shown that weight loss can lead to resumption of 
ovulation within weeks. Clark and colleagues demonstrated that even a 5% reduction 
in body mass restores ovulation and fertility[37,38]  and devised a program of exercise 
and sensible eating that has become a model across the world for treating PCOS. 
Rapid changes in body composition and fat mass can be shown during lifestyle 
change. High-protein diets seem to be as effective as high-carbohydrate diets, 
provided that fat and total calories are comparable. while lifestyle changes are 
difficult to maintain, women seeking pregnancy are highly motivated, making this a 
first-line intervention in overweight women with PCOS. Longer-term changes in 
weight are more difficult to maintain. 
 
CLOMIPHENE CITRATE: 
Clomiphene (Clomid, Serophene) is an oral anti-estrogen, may add metformin 
to help induce ovulation. This is an oral oestrogen antagonist that raises circulating 
concentrations of FSH and induces follicular growth in most women with PCOS and 
anovulation. The initial regimen is 25–50mg per day for 5 days. Therapy can be 
monitored by oestrogen levels, follicular ultrasound examination and luteal 
progesterone level (>20nmol/L). Failure of response is associated with high body 
mass index and high androgen levels. Doses up to 200mg per day can be used before 
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failure of response is established. In the rare situation in which side effects limit 
treatment, Tamoxifen can be used. Both treatments increase the risk of multiple 
pregnancy. 
LETROZOLE: 
 Another medication letrozole works to stimulate the ovaries, but it may help 
with ovulation when other medications fail. 
METFORMIN:. 
Prescribing Metformin (Glucophage, Fortamet, others), an oral medication for 
type 2 diabetes that improves insulin resistance and lowers insulin levels. This drug 
may help with ovulation and lead to regular menstrual cycles. Metformin also slows 
the progression to type 2 diabetes and aids in weight loss .Use of the insulin-
sensitizing drug Metformin at doses of 500–2500mg daily is controversial, but 
appears valuable in increasing menstrual cyclicity and pregnancy rate. A recent 
consensus statement from the Endocrine Society of Australia indicated its use in 
women trying to become pregnant.[39-42] The new insulin-sensitizing agents, the 
“glitazones” — troglitazone (now discontinued), rosiglitazone and pioglitazone — 
have been shown to be very effective for ovulationinduction,[43]but are not approved 
by the Pharamaceutical Benefits Scheme for PCOS. There is greater concern about 
the effects on the fetus of these drugs compared with Metformin, and they should not 
be used by women trying tobecome pregnant.[44] 
Another medication letrozole works to stimulate the ovaries, but it may help with 
ovulation when other medications fail. 
 
SURGERY TO THE OVARIES:  
Wedge resection of the ovaries has been abandoned because of concerns about 
pelvic adhesions, another cause of subfertility, and loss of valuable ovarian tissue. 
Ovarian diathermy or laser drilling has been used in recent years with apparently good 
results; a recent systematic review comparing drilling with clomiphene citrate and 
gonadotrophins proved equivalence in the studies examined.[45]However, like wedge 
resection, this surgery may produce pelvic adhesions. Destructive surgery to the ovary  
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should be used only after extensive discussion with the patient and not because the 
ovaries are found to be polycystic incidentally during routine laparoscopy. 
  
 
GONADOTROPHIN TREATMENT: 
Ovulation induction with gonadotrophins such as FSH has proved successful 
for at least three decades, but demands skill and experience to avoid multiple 
pregnancies and ovarian hyperstimulation syndrome. Patients start on low-dose 
recombinant FSH administered subcutaneously. Monitoring of ovarian response 
involves ultrasound examination, often with oestradiol measurement. Human 
chorionic gonadotrophin is given when one follicle reaches 16–20mm in size. Any 
more than two follicles of an appropriate size give the risk of multiple pregnancies. 
Multiple gonadotrophin cycles may be required to achieve pregnancy, but this 
approach is preferable before more invasive procedures, such as in-vitro fertilisation. 
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IN-VITRO FERTILISATION:  
Provided there is no problem other than anovulation, this has little place in the 
management of infertility resulting from PCOS. Ovulation induction by a skilled 
reproductive endocrinologist is preferable to in-vitro fertilisation because of the risks 
of hyperstimulation and multiple pregnancies with the latter procedure. 
 
LONG-TERM MANAGEMENT: 
 Women with PCOS require ongoing surveillance to detect impaired glucose 
tolerance, hyperlipidaemia, endometrial hyperplasia and consequent complications. 
Obese women, in particular, require regular (possibly annual) glucose tolerance 
testing because of the potential for rapid progression from normal to impaired glucose 
tolerance and diabetes.[46] Some investigators have suggested prophylactic use of 
Metformin in young teenagers and older women to avoid the problems of the 
metabolic syndrome. This approach is probably premature at present and is not 
recommended. Advice about improved exercise and diet is more rational, given the 
abundant data on the role of lifestyle change in preventing and treating problems of 
glucose metabolism. 
 
REGULATE YOUR MENSTRUAL CYCLE:  
To regulate menstrual cycle, recommended combination birth control pills — 
pills that contain both estrogen and progestin. These birth control pills decrease 
androgen production and break the effects of continuous estrogen, lowering risk of 
endometrial cancer and correcting abnormal bleeding. An alternative approach is to 
take progesterone for 10 to 14 days every one to two months. This type of 
progesterone therapy regulates the periods and offers protection against endometrial 
cancer. 
REDUCE EXCESSIVE HAIR GROWTH:   
Spironolactone (Aldactone) that blocks the effects of androgens on the skin. 
Because spironolactone can cause birth defects, effective contraception is required 
when using the drug, Eflornithine (Vaniqa) is another medication possibility; the 
cream slows facial hair growth in women. 
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HORMONE THERAPY: 
To correct menstrual cycle problems, birth control hormones keep endometrial 
lining from building up for too long. This can prevent uterine cancer. Hormone 
therapy also can help with male-type hair growth and acne. Birth control pills, 
patches, or vaginal rings are prescribed for hormone therapy. Androgen-
lowering spironolactone (Aldactone) is often used with combined hormonal birth 
control. This helps with hair loss, acne, and male-pattern hair growth on the face and 
body (hirsutism). 
 
REGULAR CHECKUPS:  
Regular checkups are important for catching any PCOS complications, such as high 
blood pressure, high cholesterol, uterine cancer, heart disease, and diabetes.[47-50] 
 
ANIMAL MODELS FOR THE STUDY OF PCOS 
To identify the complex nature of this disease, suitable animal models are 
needed. Researchers during the past three decades have identified different animal 
models that mimic many of the features of PCOS in women. These models have 
afforded valuable information into complex nature of PCOS. Currently, although a 
genetic component to PCOS has been identified, a specific "PCOS gene" has not, and 
therefore a specifically targeted gene deletion for PCOS as an animal model is not 
available. Therefore, the majority of PCOS models that are available to date rely upon 
external chemical treatments with steroids, steroid precursors or steroid receptor 
antagonist to achieve the pathology. Many of these models do not produce consistent 
results or cease to produce PCOS like symptoms once the treatment stops.[51] noted 
that their model for cardiovascular disease, the hypothalamic pro-opiomelanocortin 
(POMC) specific leptin-insulin double receptor knockout mouse exhibited some 
similar features to PCOS. Our recently developed theca specific Esr1specific 
knockout mouse model reproduces the clinical pathologic features of PCOS in 100% 
of animals. 
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Androgens 
Within the ovary, androgens, mainly androstenedione (A4) and testosterone 
(T), are synthesized in the theca cells. A direct role for androgen receptor (AR)-
mediated effects in the ovary and female reproductive functions has been recently 
confirmed by findings from AR knockout mouse models, where a loss of AR actions 
lead to subfertility, predominantly due to defective gonadotropin regulation, follicular 
development, and ovulation.[52, 53] 
 
Prenatal Androgen 
Prenatal androgen (PNA) treatment in sheep and monkeys results in multiple 
metabolic and reproductive abnormalities.  
 
Pre-Pubertal Androgen 
       This model exploits the association of elevated androgen levels during puberty 
and PCOS. Administration of exogenous androgens results in permanent damage to 
the ovarian tissue and recapitulated the hallmark symptoms of PCOS in an animal 
model. PPA model shows many similar features to PCOS in women with the 
exception of the hallmark increase in basal LH levels. [54,55] 
 
Letrozole 
 Letrozole is an oral non-steroidal aromatase inhibitor. Inhibition of aromatase 
prevents the conversion of androgens to estrogens and therefore this model has similar 
features to the prepubertal androgen treatment.[56]Similarly to pre-pubertal androgen, 
this model is also reliant on artificial hyperandrogenemia and does not help identify 
abnormalities upstream of hyperandrogenemia. 
 
Dehydroepiandrosterone (DHEA) 
 DHEA is sufficient to induce a hyperandrogenizedstate  in PCOS . This model 
is also reliant on artificial hyperandrogenemia and does not help identify 
abnormalities upstream of hyperandrogenemia. 
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RU486 
 Administration of RU486 on the day of estrus in rats exhibit increased basal 
LH, polycystic ovaries, ovulation blockade and metabolic defects.[57] However, this 
model is reversible and symptoms decrease upon cessation of the antiprogestin 
treatment. 
Estradiol 
 The immune system is now a well-recognized component of reproductive 
biology. Immune cells are involved in all aspects of normal reproductive function 
including ovulation, corpus luteal formation, uterine receptiveness and maintenance 
of pregnancy. Chapman and collea-gues[58] now provides evidence that aberrant 
immune function may play a role in the pathogenesis of PCOS and that PCOS may 
result from as autoimmune disease. As a consequence of this, increased vascular 
permeability in the thymus allows auto reactive T-cells to escape into the circulation. 
The ultimate effect of these “escapees” is damage to tissues throughout the body 
including the ovaries. This model offers an abrupt change in the direction of PCOS 
research. The major deficiencies in this model are a lack of hyperandrogenemia and 
the fact that the loss of regulatory T-cell function would not only impact the ovary, 
but multiple other tissues resulting in pathologies not associated with PCOS. It will be 
interesting to follow the progress of this novel concept of autoimmune responses 
resulting in PCOS in women and if, PCOS women have deficiencies in regulatory T-
cells. 
 
Hypothalamic Pro-Opiomelanocortin (POMC) Neuron Specific Leptin And 
Insulin Receptor Ko 
Hill and her colleagues were interested in insulin resistance and the 
development of type II diabetes when they developed their Pomc-Cre, 
Leprflox/floxIRflox/floxmice, effectively removing both leptin and insulin receptors 
specifically from the POMC. [59] However, together with the anticipated glucose 
intolerance and insulin deficiency these mice suffer from hyperandrogenemia and 
polycystic ovaries. These two pathological conditions secure its eligibility as a model 
for the study of human PCOS. 
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Aromatase Inhibitors 
Polycystic ovaries can be induced by androgen exposure including not only 
exogenous androgens but also as a result of secondary endogenous androgen excess. 
[60,61]
.The latter includes the rat PCOS model induced by letrozole, anonsteroidal 
aromatase inhibitor, which blocks the conversion of androgens to estrogen.[62] 
HERBAL REMEDIES 
1. Cinnamon 
Researchers from Columbia University have found that cinnamon 
supplementation can help improve menstrual cyclicity in women with PCOS. Plus, a 
pilot study published in the journal Fertility and Sterility indicates that this herb can 
help reduce insulin resistance in women with PCOS. 
 
2. Flaxseed 
Flaxseed can also be used to combat PCOS as it helps decrease androgen 
levels. It contains lignans that increase the production of sex hormone binding 
globulin (SHBG) that binds testosterone in the blood, thereby preventing it from 
wreaking havoc in the body. Plus, being high in fiber, flaxseed helps slow down 
glucose metabolism and lower cholesterol levels. The omega-3 fatty acids in this 
superfood also reduce inflammation, lower blood pressure and reduce the risk of 
chronic diseases like heart disease. 
 
3. Spearmint Tea 
Spearmint tea can also help deal with PCOS due to its anti-androgenic 
properties. Spearmint tea can help reduce hirsutism, or excess body hair, by reducing 
free and total testosterone levels and increasing luteinizing hormone (LH) and 
follicle-stimulating hormone (FSH) levels. 
 
4. Apple Cider Vinegar 
Apple cider vinegar is also beneficial for dealing with PCOS because it helps 
control blood sugar and keeps away from producing too much insulin. 
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5. Fenugreek 
Fenugreek promotes glucose metabolism in the body and improves insulin 
resistance. This in turn helps balance your hormones. It may also help lower 
cholesterol, aid weight loss and promote healthy heart functioning. 
6. Saw Palmetto 
This herb acts as an anti-androgen, blocks 5-alpha-reductase activity and 
reduces the conversion of the testosterone into a more active form called 
dihydrotestosterone (DHT). This in turn may help prevent hirsutism or excessive 
hairiness in women with PCOS. It also helps thinning hair grow back. 
7. Naturopath often suggest this herb for the treatment of PCOS because it helps 
correct the hormonal imbalance. 
8. Liquorice: 
This herbs act the effect on androgen metabolism in nine healthy women 22–
26 years old, in the luteal phase of the cycle. They were given 3.5 g of a commercial 
preparation of liquorice (containing 7.6% W/W of glycyrrhizic acid) daily for two 
cycles.[63-65] 
 
LIFESTYLE CHANGES 
 Weight loss, consuming low-calorie diet,   moderate exercise activities   might 
improve the condition. For Healthy lifestyle 
• A small amount of weight loss is likely to help balance the hormones and start up 
menstrual cycle and ovulation. 
• Eat a balanced diet that includes lots of fruits, vegetables, whole grains, and low-fat 
dairy products. 
• Get regular exercise to help you control or lose weight and feel better. 
• Avoid smoking. Women who smoke have higher levels of androgens than women 
who don't smoke. 
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LITERATURE REVIEW 
1. Chinenye Jane Ugwah-Oguejiofor, et al.,(2014)investigated the effects of 
Ficusplatiphylla on female wistar rats with esterodialvalerate (EV)- induced PCOS. 
Animal were divided into five groups.The positive control group received clomiphene 
citrate, the negative control group received distilled water and the other group received 
100mg/kg, 200mg/kg, 400mg/kg of aqueous extract. All groups were dosed for 15 days, 
except the positive control group, which was dosed for five days. On 16th day animal 
weresacrificed.Hormonal assay and histopathological studies were conducted. The 
extract treated groups showed a lower LH/FSH ratio compared with other groups. The 
progesterone levels were increased, indicating luteal phase repair. The extract treated 
group shows reversal of ovarian morphology. These data validate for the treatment of 
infertility.[66] 
 
2. Nataji,et al., (2006)evaluatedhisto-chemicalstudy of estrodialvalerate induced poly 
cystic ovary syndrome in rat. The rats were divided into treatment and control groups. 
The treatment groups were injected with intra muscular injection of estrodialvalerate. 
Whereas control group were given with sesame oil. After 63 days of hormone 
administration rats were sacrificed, ovaries were collected and processed for 
histochemical studies. These studies include localization of carbohydrate using PAS 
method, saturated and unsaturated lipid using oil Red-o, Sudan Black B, Lipase and 
alkali phosphatase. It conclude that during follicular atresia and cystic follicle formation, 
histo chemical alteration were occurred in follicular structure.[67] 
 
 
3. Somayyehsadrefozalayi,et al., (2014)studied the effect of aqueous extract of 
Foniculumvulgareonin the kidney of experimental PCOS in female rats. Animal 
segregated into G1(Normal saline), G2(perse control), G3(Toxic with estrodialvalerate), 
G4 and G5 with low and high dose of AEFV. After 4 weeks of study rats were 
sacrificed. Kidney processed for light microscopy and bio chemical parameter of serum 
were measured. The mean value of BUN(Blood Urea Nitrogen) in PCOS treated with 
low dose of AEFV and non-treated was significantly increased compared with high dose 
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of AEFV. Moreover histo-pathological changes of kidney samples were comparable in 
PCOS rats with respect to treated groups with AEFV. Aqueous Extract of fennel seed 
showed beneficial effect on renal function in PCOSrats.[68] 
 
4. Christian G Krueger, et al., (2002) postulated that combining extracts of grape seed 
(GSD) and grape skin (GSK), primary sources of grape polyphenolics, individually 
shown to inhibit platelet aggregation, might enhance their individual antiplatelet effects. 
This hypothesis was examined in vitro (human platelets) and ex vivo (dog platelets) by 
studying the effects of the extracts on collagen-induced whole blood platelet 
aggregation. The results suggest that the components of GSD and GSK, when present in 
combination as in red wine, grape juice or in a commercial preparation containing both 
extracts, exhibit a greater anti platelet effect than when present individually.69 
 
5. Tamaro S Hudson, et al., (2007) studied the inhibition of prostate cancer growth by 
Muscadine Grape Skin Extract (MSKE) and Resveratrol through distinct mechanisms. 
MSKE significantly inhibited tumour cell growth in all transformed prostate cancer cell 
lines. These results show that MSKE and resveratrol target distinct pathways to inhibit 
prostate cancer cell growth in this system and that the unique properties of MSKE 
suggest that it may be an important source for further development of chemopreventive 
or therapeutic agents against prostate cancer.70 
 
6. Revilla, I, et al., (1999) identified anthocyanin derivatives in grape skin extracts and red 
wines by liquid chromatography with diode array and mass spectrometric detection. The 
different options MS detection is investigated in order to achieve the best conditions for 
detection and identification of anthocyanins by LC–MS. A method for separation of 
these compounds that enables the main molecules in wines to be identified by direct 
analysis, without any previous preparation, is proposed. The anthocyanin composition of 
different red grape skin extracts and commercial monovarietal wines were determined by 
this method.71 
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7. Soares de Moura, R, et al., (2010) evaluated the antihypertensive, vasodilator and 
antioxidant effects of a grape skin extract. Oral administration of GSE significantly 
reduced systolic, mean and diastolic arterial pressure in Wistar rats with 
desoxycorticosterone acetate-salt and NG- nitro-L-arginine methyl ester (L-NAME) 
induced experimental hypertension. In the rat isolated mesenteric vascular bed pre-
contracted with norepinephrine, bolus injections of GSE induced endothelium-dependent 
vasodilatation that was substantially inhibited by L-NAME. Lipid peroxidation of 
hepatic microsomes estimated as malondialdehyde production was            concentration-
dependently inhibited by GSE. The results from the experiment provide clear evidence 
that the extract has got antihypertensive, vasodilator and antioxidant action.72 
 
 
8. Andrea Fernandes Emiliano, et al., (2011) examined the effects of grape skin extract on 
metabolic disorders and oxidative stress in adult offspring of rats fed with a high-fat diet 
(HFD) during lactation. Adiposity, Plasma Triglyceride, Glucose Levels, Insulin 
Resistance and Plasma Oxidative Damage were decreased by the extract.  From the 
results its concluded that the grape skin extract has got protective action on both 
oxidative stress and metablic disorders.73 
 
9. Karla Maria Pereira Pires, et al., (2011) studied the preventive effect of grape skin 
extract on pulmonary oxidative response in mice exposed to cigarette smoke (CS). The 
administration of GSE inhibited ALI and oxidative damage induced by CS. This is 
associated with decreased MMP-9 (Matrix Metallopeptidase-9) activity, decreased 
number of inflammatory cells in the bronchoalveolar lavage fluid, and reduced levels of 
lipid peroxidation. The study indicates that alteration of the oxidant-antioxidant balance 
is important in the pathogenesis of CS-induced ALI (acute lung inflammation) and 
suggests lung protective effects of GSE treatment in the mouse.74 
 
10. Roberto Soares de Moura, R, et al., (2012) investigated the effect of grape skin extract 
on hyperglycaemia and the insulin-signalling cascade in alloxan-treated mice. Glycemia 
values, insulin resistance and glucose transporter (GLUT-4) content was determined. 
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The results suggest that the grape skin extract has hypoglycaemic and antihyperglycemic 
effects, which are independent of an increase in insulin release but are probably 
dependent on an increase in insulin sensitivity resulting from an activation of the insulin-
signalling cascade in skeletal muscle.75 
11. Chantal Barthomeuf, et al., (2005) noted the inhibition of sphingosine-1 phosphate- and 
vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin 
polyphenols correlates with a decrease in early platelet-activating factor synthesis. The 
red grape skin polyphenolic extract prevents and inhibits angiogenesis decreases the 
basal motility of endothelial and cancer cells, and reverses the chemotactic effect of S1P 
(Sphingosine 1-Phosphate) and VEGF (Vascular Endothelial Growth Factor) on bovine 
aortic endothelial cells (BAECs) as well as the chemotactic effect of conditioned 
medium on human HT-1080 fibrosarcoma, human U-87 glioblastoma, and human 
DAOY medulloblastoma cells. The dual inhibition of S1P- and VEGF-mediated 
migration of endothelial cell and of serum-stimulated migration of U-87 cells suggests a 
usefulness of SGE against highly invasive human glioblastoma.76 
 
12. Katherina Fernández, et al., (2010) evaluated the inhibitory effect of grape seed and 
skin proanthocyanidins extracted from Vitisvinífera L on the angiotensin-converting 
enzyme.  ACE activity was measured by quantitative HPLC, measuring the hyppuric 
acid (HA) produced from the hydrolysis of hippuryl-L-histidyl-L-leucine (HHL) by 
ACE. From the result its concluded that the grape skin proanthocyanidins has got more 
inhibitory power than the grape seed proanthocyanidins.77 
 
13. HeeKyoung Jung, et al., (2011) studied the inhibitory action of grape skin extract on 
adipogenesis- and lipogenesis-related gene expression in 3T3-L1 adipocytes through the 
peroxisome proliferator-activated receptor-γ signaling pathway. GSE extract treatment 
decreased expression of aP2, Fas, and Tnfa, known markers of adipogenesis. These 
findings demonstrate the antiadipogenic effects of GSE on 3T3-L1 adipocytes at the 
genetic level, primarily on the PPARγ signaling pathway.78 
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14. Shao Jian Zheng,Kequan Zhou, et al., (2010) investigated whether Grape skin extract 
inhibits mammalian intestinal α-glucosidase activity and suppresses postprandial 
glycemic response in streptozocin-treated mice. This study showed that the grape skin 
extract (GSE) significantly inhibited mammalian intestinal α-glucosidases and reduced 
postprandial blood glucose by 30.9% in the streptozocin- treated male mice following 
starch challenge and thus can be used as a novel dietary opportunity for diabetes 
management.79 
 
15. Alaa El-Din A. Bekhit, et al., (2011) evaluated the in vitro Antioxidant activities, 
sensory and anti-influenza activity of grape skin tea infusion. The antioxidant activities 
(DPPH_ scavenging capacity and superoxide anion radical scavenging capacity), total 
phenolics, the polyphenolics profile and objective colour measurements (CIELab) were 
determined on freeze-dried water extracts of all five tea infusions, hibiscus and green tea. 
From the results its confirmed that the infusion exhibited weak antioxidant and anti viral 
action.80 
 
16. Sonia Hamlaoui, et al., (2012) have evalauted the protective effect of grape seed and 
skin extract on high dosage garlic-induced renal oxidative stress. Rats were 
intraperitoneally injected with garlic (5 g/kg bw) or GSSE (500 mg/kg bw) or a 
combination of garlic and GSSE at the same doses daily for one month. They concluded 
that high garlic dose induced a pro-oxidative state characterized by the Fenton reaction 
between H2O2 and free iron, inducing Ca2+ depletion, while GSSE exerted antioxidant 
properties and Ca2+ repletion.81 
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FOCUS OF THE PRESENT STUDY 
 
The present study was undertaken to find out the   potential activity of 
Vitisviniferalinn against Estrodialvalerateinduced Poly cystic ovary syndrome in 
rats.From time immemorial mankind's efforts and ultimate aim have been to seek 
eternal happiness. And his endeavour has been to overcome and seek appropriate 
remedies for things that stand in his way. Plants have played a weighty role in 
maintaining human health and improving the quality of human life for thousands of 
years and have several precious components of 
medicines,seasonings,beverages,cosmeticsand dyes.Herbal medicines are based on the 
premise that plants contain natural substance that can promote health and alleviate 
illness.In recent times focus on plant research has increased all over the world and 
large evidence has collected to show immense potential of medicinal plants used in 
various traditional systems. 
 
Today we are witnessing a great deal of public interest in the use of herbal 
remedies.Many western drugs had their origin in plant extract.There are many 
herbs,which are preponderantly used to treat cardiovascular problems,liver 
disorder,central nervous system,digestive system,metabolic disorders and for 
Neuroprotective effects.Given their potential to generate significant therapeutic 
effect,they can be useful as drug or supplement in the treatment in the management of 
many diseases.Herbal drug or medicinal plants,their extract and isolated compounds 
have demonstrated spectrum of biological activities.Such have been used and 
continued to be used as medicine in folk-fore or food supplement for various 
disorders. 
 
Vitisviniferacontain several medicinally active compounds including 
polyphenols(stilbenes and flavanoids),  tannins and anthocyanins. Among the plant 
part the grape skin has got the highest concentration of polyphenols. The different 
parts of the plant Vitisvinifera Linn. has been used in different system of traditional 
medication for the treatment of diseases and ailments of human beings.  
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Vitisviniferaon Estrodialvalerate induced PCOSand also planned to study the 
changes. Evaluation of stage of Estrous cyclicity by vaginal smear.Evaluation of 
Vaginal Cytology.Evaluation of serum Hormonal parameter: 
 
 Follicle stimulating hormone 
 Luteinizing hormone 
 Estradiol 
 Progesterone  
 Testosterone 
. 
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PLAN OF WORK 
 
 Induction of Polycysticovary in rats using intramuscular injection of Estradiol 
valerate. 
 
 Evaluation of stage of Estrous cyclicity by vaginal smear. 
 
 Evaluation of Vaginal Cytology. 
 
 Evaluation of serum Hormonalparameter : 
 Follicle stimulating hormone 
 Luteinizing hormone 
 Estradiol 
 Progesterone  
 Testosterone 
 
 Determination of ovarian weight, ovarian morphology, Follicular diameter & 
follicular thickness. 
 Histological examination of the ovaries. 
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PLANT PROFILE 
Vitisvinifera Linn. 
Family: - Vitaceae 
Botanical Name         : VitisviniferaLinn. 
Family              : Vitaceae 
SCIENTIFIC CLASSIFICATION81 
Kingdom  :   Plantae 
Division  :  Magnoliophyta 
Class   :  Magnoliopsida 
Order   :  Vitales 
Family   :  Vitaceae 
Genus   :  Vitis 
Species  :  V.vivnifera 
VERNACULAR NAMES82 
English                        : Common Grapes 
Tamil              :  Drakshai, Kodimundiri, Gostanidraksha, Kotumuntiri 
Hindi  :  Munakka, Angur, Dakh, Drakh 
Malayalam     :  Munthringya,  Muntiri. 
Telugu   :  Drakshakottai, Drakshai 
Kannada  :  Draksha, Angura, Drakshi 
Marathi            :  Draksha, Angur 
Gujarathi  : Drakh, Darakh 
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Bengali             :  Angurphal, Drakhyaluta, Maneka 
Oriya   :  Drakya, Gostoni, Onguro 
Punjabi  : Munaca  
Sanskrit  :  Gostani, Mrdvika 
Urdu                          :  Munaqqa 
Assamese                 :  Dakh, Munaqqa 
DISTRIBUTION  
It is cultivated in Jammu-Kashmir, Himachal Pradesh, Uttar Pradesh, 
Rajasthan, Punjab, Haryana, Delhi, Maharashtra, Karnataka, Andhra Pradesh and 
Tamil Nadu. 
BOTANICAL DESCRIPTION  
A large decideous tendril climber, tendrils leaf opposed often bifid. Leaves are 
simple,more or less deeply 3-5 lobbed, orbicular-cordate, irregularly toothed glabrous 
above, tomentose beneath. Flowers are long peduncled, leaf- opposed cymes, greenish 
or white. Fruits (berry) are globose, ovoid or oblong, varying in size, pale green or 
purple with 2-4 seeds which are oblong-obovoid, brown, with a discoidal tubercle on 
the back. 
PARTS USED  
Ripe fruit (dried), leaf, stem, flower, dried skin, seed 
CHEMICAL CONSTITUENTS83 
The major constituents present in grape are simple phenols, flavonoids, 
anthocyanins and stilbenes. The major constituentspresent in grape are simple 
phenols, flavonoids, anthocyanins, stilbenes.Phenols are the third most-abundant 
constituent in grapes; carbohydrates and fruit acids are the most- and second most-
abundant, respectively. The total extractable phenolics in grapes are present at ≤10% 
in the pulp, 60-70% in the seeds, and 28-35% in the skin. Various phytoconstituents 
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have been isolated from the various parts of Vitisvinfera, mainly from shoot, leaves, 
fruit, seed, skin, and flower which are shown below in the table no: 1. 
SL.No PLANT 
PART 
CHEMICAL CONSTITUENTS 
 
1 
 
SHOOT 
• Fatty Acids: Palmitic, Stearic, Oleic, Linoleic and Linolenic 
Acids 
 
 
 
2 
 
 
 
LEAF 
• Flavanols: Isomer of Quercetin and Rutin. 
• Terpenes: Linalool, Geraniol, and α-Terpineol 
• Tannins: Isovitaligin, Vitaligin, Brevilagin, Ellagitannins 
• Minerals: Potassium and Calcium Bitartrate, Calcium Malate 
• Phenolic Acids: Caffeic Acid 
• Essential Oil: Linalool, Geraniol, Elemol Acetate, α-Terpineol 
• Sugar    
 
 
 
3 
 
 
 
FRUIT 
• Sugars: Glucose, Fructose, Galactose, Mannose, Arabinose, 
Rhamnose 
• Amino Acids :Alanine,Arginine And Proline 
• Tannins 
• Terpene : Oleanolic Acid 
• Anthocyanins: Malvidin, Cyanidin, Delphidin 
• Flavonoids: Procyanidin 
• Carotene,Minerals,Proteins,Waxes,Xanthophylls,Vitamins 
• Pectin 
• Fruit Acids: Malic Acid, Tannic Acid, Dehydroascorbic Acid 
• Sterol: Cholesterol, Sitosterol, Ergosterol,  
 
4 
 
SEED 
 
• Flavanols: Catechin, Epicatechin, Taxifolin, Quercetin, 
Gallocatechin, Procyanidin 
• Semi drying oil contain palmitic, stearic, oleic and linoleic 
acids along with sitosterol and tocopherols 
 
5 
 
 
SKIN 
• Anthocyanins: Malvidin, Peonidin, Petunidin, Delphinidin 
• Stilbene: Resveratrol 
• Flavonoids:Procyanidin, Catechin, Epicatechin 
• Tannins 
• Sugars and Minerals 
• Acids : Tartaric Acid 
6 FLOWER • Sesquiterpene: Valencene, α- and β-Farnesene, β-Bisabolene, 
α-Humulene, β- and δ-Selinene, γ-Cadinene and Nerolidol 
 
TABLE No.1 
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MEDICINAL PROPERTIES84 
Fruits 
The fruits are sweet, refrigerant, laxative, demulcent, cardiotonic, haematinic, 
haemostatic, diuretic, aphrodisiac, rejuvenating, nervine tonic, febrifuge,depurative, 
antispasmodic, digestive, stomachic,expectorant and tonic. They are useful in burning 
sensation, dipsia, constipation, amentia, cardiac debility, haemoptysis, haemorrhages, 
anaemia, strangury, fever, leprosy, skin diseases, dyspepsia, colic, flatulence, cough, 
asthma, bronchitis, Bright's disease, goutandjaundice. 
Leaves  
The leaves are astringent, anodyne, diuretic, depurative and useful in 
cephalalgia, strangury, scabies, skin diseases, syphilis, haemorrhoids, diarrhoea, 
splenomegaly and vomiting. 
Stem 
The ash of the stem is good for arthralgia, vesical calculi, haemorrhoids and 
orchitis. Sap of young branches is used in skin diseases. 
Flowers 
The flowers are expectorant, emmenagogue and haematinic, and are useful in 
bronchitis, liver disorders, anaemia, amenorrhoea and dysmenorrhoea. 
Skin 
The grape fruit skin has got antiplatelet, anticancer and anti oxidative action. 
The skin extract is also used for hypertension and diabetesIt has also got anti 
adipogenic action. 
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PREPARATION OF EXTRACT 
 
Hydroalcoholic extracts of Grape Skin Extracts (GSE) (yield = 7.5%) were 
prepared by routine methods using rotary vacuum evaporator (Roteva, Equitron, 
Medica Instruments Mfg.co, Mumbai) and programmable freeze dryer (Allied 
Frost,Mumbai) from dried Grape skin. A voucher specimen of Grape skin has been 
deposited at the herbarium, in the Department of Pharmacognosy, K.M.Collegeof 
Pharmacy (No. GS2013-09:KMCP). Powders of GS extracts are light brown color. 
GS extracts were stored in a refrigerator at −20◦C to protect from light and 
degeneration, and they are well soluble upto 60mg/mL concentration levels in 
distilled water used as vehicle as clear light brown solution. 
 
Extraction Procedure 
The fresh plant fruit of Vitisviniferawere collected and authenticated. The 
fruits were peeled off and the skin was dried in the shade. Then the shade – dried 
grape skin were pulverized to get coarse powder, sieved under mesh no.60.  
Materials  
 Rotary Evaporator 
 70%ethanol 
 distilled water 
 Shade dried grape skin powder 
Methods 
500gm of coarsely powdered dried skin of Vitisvinifera were extracted with 2 
liters of 70% Ethanol at 70oC temperature, for 1 hour in a 20 liter round bottom flask 
with condenser attached. Filter and collect the extract. Repeat extraction with 2 liters 
of 70% Ethanol. Filter and collect the extract. Extract the marc with2 liters of water. 
Filter and combine the extracts. The combined extract was evaporated to dryness 
under reduced pressure in a Buchi RotaryEvaporator (Switzerland) at 65°C, to obtain 
a brownish colour residue. This extract was used for the experimentation. 
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PHARMACOLOGICAL EVALUATION 
 
To a large world population, medicinal plants are the only source to prevent 
and treat various diseases.Medicinal plants form main source of health care due to 
better acceptability and fewer side effects. Herbal plants have been used since 
centuries to correct disorders caused by the hormonal imbalance related to female 
reproductive system.[91-93] Current research work is to investigate the effect of 
HAEGSE  in treatment of Estradiol valerate induced PCOS. The current research 
work focuses on normalization of estrous cycle in PCOS after treatment with 
VitisviniferaLinn. 
 
EXPERIMENTAL MODEL 
 
For the study of poly cystic ovary syndrome an experimental model is selected 
in such a way that it would satisfy the following condition 
• The animal should develop cyst rapidly. 
• Pathological changes in the site of induction should result from PCOS formation. 
• The symptom should be ameliorated or prevented by a drug treatment effective in 
humanbeings. 
• The drug tested should be administered orally. 
• Drug dosage should approximate the optimum therapeutic range for human, scaled the 
test animal weight. 
 
Selection grouping and Acclimatization of Laboratory Animal 
Female albino rats (180-220gm) are produced from animal experimental 
laboratory, and used thoughout the study. They are housed in micro nylon boxes in a 
control environment (temp 25+20c) and 12 hrs dark\ light cycle with standard 
laboratory diet and water ad libitum. The study is conducted after obtaining 
institutional animal ethical committee clearance. As per the standard practice the rats 
are segregated based on their gender and quarantined for 15 days before the 
commencement of the experiment. They are fed on healthy and maintained in 
hygienic environment in our animal house. 
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Technique for inducing PCOS 
 Technique for induction of PCOS in animals by chemically induced (using 
Esterodialvalerateoil, Letrazole, Androgen, Prenatal Antrogen, 
Dehydroepiandrosteroneetc)have been used in experimental studies of PCOS activity. 
 
Induction of PCOS in the Animals 
         In the present study, Estradiol valerate induced PCOS is used to evaluate the 
treatment of PCOS.[79]Sixty adult virgin Wistar rats of approximately 10-12 weeks of 
age, weighing between 180-220gm and with regular 4-5 day estruscycles as assessed 
by vaginal smear, were used for the study [85]. Five of the rats were kept as controls, 
and the others were each given intramuscular injection of 4 mg EV in an oily solution 
per rat.[86,87] Vaginal smears were examined daily in all animals. Cessation of 
cyclicity, which was shown by the persistent cornification of vaginal smears, was 
used as a criterion forselection into the PCOS group. 
 
Vaginal Smears  
 The stage of cyclicity was determined by microscopic analysis of the 
predominant cell type in vaginal smears. Estrous cyclicity was monitored by vaginal 
smears obtained between 0800 and 1200 hours, and it was assessed by analysis at the 
light microscopy level of the relative proportion of leukocytes, epithelial and 
cornifiedcells found in daily vaginal lavages, which characteristically change during 
different stages of the estrous cycle. The rat estrous cycle (estrus, diestrus1, diestrus2, 
and proestrus) usually lasts about 4 days, in controls or PCO rats.[88] 
  
Vaginal cytology 
 Vaginal smears were obtained daily. The rats were held at the thorax, ventral 
side upper, whilst providing lumbar support. Vaginal secretions were collected using 
cotton-tipped with a drop of physiological saline. After about 1-2 inches of the swab 
was inserted into the vagina of the female rats and the end was rotated through 2-3 
revolutions (which allowed the cotton tip to pick an adequate load of cells), the swab 
was then gently withdrawn and the tip of the cotton rolled along the length of a glass 
slide. The dried smear was fixed by dipping it in a container of 70% alcohol. The 
slides were then stained with 0.5% methylene blue solution, rinsed in tap water and 
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examined under ×10 objective lens (without the condenser lens) of a light 
microscope.[89,90] 
 
Treatment Protocol     
Thirty animals of Wistar rat were randomly selected and divided into five 
groups (n=6) and housed as such (6 rats per cage). All the animals in four groups were 
injected with Estradiol valerate by intra muscularly and the remaining one group is 
normal control group. The rats were allowed to establish PCOS for 30 days.[91] After 
30 days, groups in G4 & G5  were dosed orally by gavage for 15 days,  whereasrats in 
the standard group was dosed for 5 days. 
Group 1 served as the normal control.  
Group 2 served as the PCOS control. Group 1 and 2 receives normal diet and  
water.  
 Group 3 served as the positive control, was treated with injection Clomiphene  
citrate at 20 mg/kg body weight, Intra peritoneally.[92] 
Group 4 served as the treatment control, treated with Hydroalcoholic extract 
ofGrape skin extract(HAEGSE) at 200 mg/kg body weight, through 
orally. 
Group 5 served as treatment control which was treated with Hydroalcoholic 
extract ofGrape skin extract(HAEGSE) at 400 mg/kg of body weight,  
through orally.[93] 
    
 On 16th day, Six animals from each group (Control and PCO) were randomly selected 
and anaesthetised with ether. Blood samples were collected by retro orbital puncture, 
and the serum were used for hormonal assays (FSH, LH, estradiol, progesterone 
andtestosterone).[91] The ovaries were excised and weighed, and histopathological 
examination was conducted on the ovaries.  
 
Serum hormonal assays 
 Serum testosterone, follicle stimulating hormone (FSH), luteinizing hormone 
(LH), progesterone and estradiol were measured usingan enzyme immunoassay kit for 
the quantitative determination ofthe corresponding hormones. 
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Organ weight: 
 On the 16th day, some body organs of rats in all treatment groups except the 
Positive group were excised and weighed; organs from rats in the Positive group were 
instead excised and weighed on the 6th day. 
 
Histopathological examination: 
 The excised ovaries were fixed inBouin’ssolution. They were dehydrated in an 
ascending series of alcohol, cleared in xylene and embedded in paraffin wax that 
melted at 60oC. Serial sections were mounted on 3-aminopropyl triethsilane-coated 
slides and dried for 24 hours at 37ºC. The sections on the slides were deparaffinised, 
hydrated and stained with MayerÊshematoxylin and eosin dyes; they were then dried 
and mounted for histology. The ovaries were viewed at 40x magnification using the 
Scope photo 3.0 imaging device (Scope Tek DCM 200 (USB 2.0, Hangzhou Scope 
tekOpto-Electric Co Ltd). The diameter and thickness of the cystic follicles were 
measured. The cystic follicles were defined by thickened and fibrotic cortex with a 
prominent outer theca and internal layer.[91] 
 
Histology 
 The ovaries from toxic controls (EV-treated), standard &treated  groups  were 
removed, cleaned of adherent connective fat tissue, andtissue samples were fixed in 
10% formaldehyde buffer  for histological examinations.Ovaries were imbedded in 
paraffin, cut in 8-µm sections, and stained with hematoxylin and eosin examined by 
light microscopy [hematoxylin and eosin staining) Ovaries were examined for 
evidence of polycystic morphology, as described previously.[81] 
 
Statistics  
 The results are expressed as Mean ± SEM. Data was evaluated using ONE 
WAY ANOVA followed by Newman – Keul’s multiple range test. Probability values 
less than (p< 0.01) were considered significant. 
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RESULTS 
 
Effect of Hydroalcoholic extract of grape skin extract (HAEGSE) on LH in EV 
induced PCOS rats  
 Estradiol valerate (EV) treatment causes significant rise in LH levels & 
lowering of FSH levels in toxic control (G2) compared to normal control groups (G1) 
at P<0.001. The LH /FSH ratio was significantly different from the control groups. 
An elevated LH/FSH ratio observed in toxic group whereas extract treated groups i.e., 
both doses of (HAEGSE)(200mg and 400mg/kg)showed a lower LH/FSH ratio & 
significant decrease (p<0.01) in LH & rise in FSH levels when compared to toxic 
control group. (Table: 2) 
 
Effect of Hydroalcoholic extract of grape skin extract (HAEGSE) Estradiol in 
EV induced PCOS rats 
There was statistically significant decrease in estradiol levels with Estradiol 
valerate (EV) injection after 30 days (p<0.01). Concurrent administration of HAEGSE   
for 15 days showed significant rise in estradiol levels (p<0.01). Animals in Standard 
group also showed significant rise in estradiol levels. (Table: 2) 
 
Effect of Hydroalcoholic extract of grape skin extract (HAEGSE)on 
progesterone in EV induced PCOS rats 
Toxic control group i.e., treated with estradiol valerate had shown significant 
lowering of progesterone. But treatment with HAEGSE at both doses (200mg/kg and 
400mg/kg) along with EV was able to increase the progesterone levels (p<0.001) to 
near normal values significantly. Similar results were also observed in standard group. 
(Table: 2) 
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Effect of Hydroalcoholic extract of grape skin extract (HAEGSE)on testosterone 
in EV induced PCOS rats 
There was   no significant rise in testosterone levels after exposure of rats to 
estradiol valerate (p<0.01) for 30 days. Treatment with HAEGSE at two doses 
200mg/kg and 400mg/kg for 15days doesn’t show any significant changes in 
testosterone levels. Similar results were observed after clomiphene treatment. 
(Table:2) 
Effect of Hydroalcoholic extract of grape skin extract (HAEGSE)on ovarian 
morphology: 
 Ovaries of toxic control (Estradiol valerate) group exhibited more cystic 
follicles compared with other groups but these were not evident in extract control 
group. Both the 200mg/kg & 400mg/kg showed normal follicle at different stage of 
development. There was evident of arteric follicles present in 200mg/kg. The group 
that received 400 mg/kg showed numerous healthy developing follicles. (Table: 3) 
 
Effect of Hydroalcoholic extract of grape skin extract (HAEGSE) on follicular 
diameter & thickness: 
 The follicular diameter & thickness of the cysts in PCOS treated group were 
increased whereas it was reduced in standard & extract treated groups. (Table: 3) 
 
Effect of Hydroalcoholic extract of grape skin extract (HAEGSE) on ovarian 
weight: 
 The ovarian weight of EV control group showed a significant decrease 
(p<0.01), when compared with other groups, whereas in treatment control group 
200mg/kg & 400mg/kg it was restored to near normal values. (Table: 3) 
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Table No.2 Effect of Grape skin extract on serum hormone in Estradiol valerate 
induced PCOS 
 
GROUP LH FSH Estradiol TSN PRGSN 
G1 6.146±0.33 8.27±0.25 54.12±2.31 0.28±0.04 14.15±0.61 
G2 11.36±0.75**a 2.26±0.235**a 14.32±0.82**a 0.37±0.02**a 7.055±0.712**a 
G3 5.25±0.38 7.02±0.46 46.49±1.74 0.32±0.02 12.12±0.29 
G4 3.70±0.18**b 6.63±0.53**b 38.17±1.33**b 0.34±0.01**b 10.8±0.72*b 
G5 4.57±0.21**b 6.13±0.56**b 41.18±0.92**b 0.32±0.01**b 11.60±0.76*b 
      
G1- Normal,    G2-Toxic,   G3-Standard,  
G4-Low dose (HAEGSE),  G5-High dose(HAEGSE) 
All values expressed as means ± SEM for 6 animals in each group. 
**a- Values are significantly different from Normalcontrol (G1) at P<0.001 
**b- Values are significantly different from PCOS control (G2) at P<0.001  
*b- Values are significantly different from PCOS control (G2) at P<0.01 
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Table No.3 Effect of Grape skin extracts on ovarian morphology of PCOS rats 
Dose mg.kg 
ovarian 
feature 
Normal Toxic control Std control Low dose High dose 
Atretic follicle 0.00±0.00 4.43±0.307 1.12±0.05 3.06±0.17**b 0.05±0.11*b 
Cystic follicle 0.00±0.00 10.55±1.21 3.7±10.58 0.00±0.00 0.00±0.00 
Cystic follicle 
diameter 
0.00±0.00 87.73±2.367 71.19±2.35 0.00±0.00 0.00±0.00 
Cystic follicle 
thickness 
0.00±0.00 42.35±1.48 34.63±2.18 0.00±0.00 0.00±0.00 
 
G1- Normal,    G2-Toxic,    G3-Standard,  
G4-Low dose (HAEGSE),  G5-High dose (HAEGSE) 
All values expressed as means ± SEM for 6 animals in each group. 
**b- Values are significantly different from PCOS control(G2) at P<0.001 
*b- Values are significantly different from PCOS control(G2) at P<0.01 
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CHART.1 - LUTEINISING HORMONE 
 
 
CHART.2 - FOLICLE STIMULATING HORMONE 
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CHART.3 - ESTRADIOL 
 
 
 
CHART.4 - TESTOSTERONE 
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CHART.5 - PROGESTERONE 
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HISTOPATHOLOGICAL EXAMINATION 
G1: NORMAL CONTROL (10ml/kg Normal saline) 
 
Fig.13 
 Section of ovary from normal rat showing the presence of 
antralfollicle,Carpusluteum, oocyte surrounded by Granulosa cells and theca layer  
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G2: TOXIC CONTROL (Estradiol valerate4mg/kg) 
 
Fig.14 
Section of ovary from PCOS rat exhibiting many cystic degenerating follicle 
and arteric follicle with degenerated granulosa layer 
 
 
 
 
 
                         
Results 
 
54 
 
 
G3: STANDARD CONTROL (Clomiphene Citrate 20mg/ml) 
 
 
Fig.15 
Section of ovary from PCOS rat treated with clomiphene citrate showing the 
presence of normal follicle with clearantrum, Oocyte in granulosa layer. 
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G4: TREATMENT CONTROL 
              (LOW DOSE HYDROALCOHOLIC EXTRACT OF GRAPE SKIN 
EXTRACT (HAEGSE) 200mg/kg) 
 
 
 
Fig.16 
Section of ovary from PCOS rat treated with low dose of Hydroalcoholic 
Extract of grape skin extract 200mg/kg shows mild degenerative follicle and absence 
of cystic, arteric follicle 
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G5:TREATMENT CONTROL                                                                                                     
(HIGH DOSE HYDROALCOHOLIC EXTRACT OF GRAPE SKIN EXTRACT 
(HAEGSE) (400mg/kg) 
 
 
 
Fig.17 
 
Section of ovary from PCOS rat treated with high dose of Hydro alcoholic 
Extract of grape skin extract 400mg/kg shows the presence of developing 
regenerating follicle and carpus luteum,Oocytes with in Granulosa layer 
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DISCUSSION 
  PCOS has been considered a progressive multiglandularendocrinopathy 
where thedelicatebalance of the hypothalamic–pituitary–adrenal– ovarian axis is 
disturbed, resulting in a failure of thecyclic reproductive mechanism.[94,95]A total loss 
of the cyclicreproductive changes appears to follow a phase of irregular rhythmicity in 
rats experimental PCOS.[96]The precise cause of polycystic ovarian syndrome is 
unknown; however, it is considered to be a complex multi-genetic disorder 
characterized by disordered gonadotropin release, dysregulation of steroid genesis, 
insulin insensitivity, chronic annovulation, menstrual irregularities, clinical or 
biochemical hyperandrogenism, and ultrasound data of polycystic ovaries.[97,98,99] 
      Although many models can be used to study PCOS, induction of PCOS by 
Estradiol valerate can also be considered as one of the best model for studying PCOS. 
Hence, in terms of exhibiting the majority of reproductive and endocrine symptoms 
associated with PCOS, rodent PCOS models appear to closely parallel the human 
condition.This study investigated the effect of Hydroalcoholic extract of Grape skin 
extract on the serum levels of LH, FSH,estradiol, testosterone & progesterone in EV 
induced PCOS. After 30 days of PCO induction, animals were analysed both 
harmonically &histologically, on 16th day after treatment with hydroalcoholic extract, 
animals were also analysed irrespective of their estous cycle. 
  In PCOS condition, normal gonadotropin-ovarian axis is disturbed results in 
hormonal imbalancereflected by the higher levels of LH, lower FSH levels and 
reversal of LH: FSH ratio. An elevated LH/FSH ratio and anovulation are typical 
findings in women with PCOS.[100,101]The mechanism for this LH hyper secretion is 
not entirely clear, but recent data suggest that in anovulatory PCOS condition, the 
predominant reason for high serum LH concentrations is abnormal negative feedback 
on LH secretion mediated by either estradiol or progesterone.[102]The extract treated 
groups shows better reduction in this LH/ FSH ratio indicate that extract could reverse 
PCOS condition. 
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Oestrogen similar to other steroids become altered in PCO.[103]Normally, 
testosterone and androstenedione are converted to estradiol and estrone, respectively, 
with the help ofcytochrome P450 aromatase, which plays an important role in ovary’s 
hormonal balance. The level of estradiol is very minimum in PCOS rats since the 
metabolic conversion is very slow.Repetitive administration of HAEGSE led to 
significant rise in estradiol.Similarly, the reduction in the level of progesterone in the 
PCOS-induced animals could be responsible for the 
persistentoestrusphase.[104]Elevation in the concentration of serum progesterone by  
HAEGSE may be responsible for the reversal of the luteal phase dysfunctionand 
restoration of normalcy of the estrous cycle. Our study showed that Grape skin 
extractinduced an increase in serum estradiol implies that plant causes marked 
improvement in endocrine function and recovery of ovulary functions in the 
rats.Hyperandrogenism (as a result of high testosterone levels) which is evident in 
human PCOS.[105,106] was not present in this  animal model of EV induced PCOS.[107] 
Therefore no effect of the extract on androgen levels was observed using this model 
of PCOS induction. 
 Ovarian weight in PCOS induced rats was more than the normal rats which is 
in accordance with earlier findings.[108-111]Treatment with HAEGSE prevented further 
increase in ovarian weight &  returned to normaly.The biochemical results are also 
supported by histopathological observation of light microscopy.Thehistomorphometry 
of  PCO was a suitable measurement for describing the cystic status  because 
differences were observed in the morphological characteristic and in the presence or 
absence of follicular cysts.[119]It is reported that the histopathological  study of  PCOS 
induced rats shows the formation of poly  cysts in the ovary.[112,113]Ovaries exhibited 
increased follicle atresia and multiple cysts with thin granulose cell layers and 
thickened theca cell layers.[114]After  treatment with extract of Grape skin extractPCO 
condition was reversed, number of cystic follicles reduces & foundnumerous healthy 
follicles at different stage of development. Thisindicate that treatment group shows 
marked recovery of ovarian tissue and the animals may probably be preparing for 
ovulation.  
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Furthermore treatment with HAEGSE brought back feedback inhibition of 
gonadotropin (LH & FSH) along with corresponding increase in estradiol 
&progesterone.All these together emphasize the ability of extract in attenuating 
clinical, biochemical, histological features of PCOS. The presence of flavonoids in 
HAEGSEmight account for pharmacologicaleffect.[115]Again since PCOS condition 
has been reported  to reduce the level of antioxidant enzyme/molecule apart from that 
flavonoids reported to posses playing an antioxidant role in PCOS 
rats.[116]Antioxidants play an important role in protecting the human body against 
damage from reactive oxygen species.[117] Plants containing phenolic compounds, in 
particular flavonoids have been reported to exhibit strong antioxidant 
properties.[118]These phytochemicals may be responsible for acclaimed folklore  use 
of plant in management of gynecological problem. 
PLANT PROFILE 
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Conclusion 
 
60 
 
CONCLUSION 
 
 In PCOS women, normal gonadotropin-ovarian axis is disturbed. This is 
reflected by the higher levels of LH, lower FSH levels and reversal of LH: FSH ratio. 
FSH levels in PCOS show lower than normal values whereas after treatment it proves 
significant variations. Androgen dynamics involving testosterone doesn’t show any 
significant variation. Estrous cycle of the rats was disturbed when they were in 
polycystic ovary condition were returned to normalcy after treatments. The 
reproductive system and ovary weight of normal rats increased with estradiol valerate 
injection which normalizes after treatment withGrape skin extract.Polycyst observed 
in all groups except normal control was completely reduced. Polycystic Ovarian 
Syndrome (PCOS) is one of the most common female endocrine disorders which may 
leads to infertility. Herbal drugs have promising role in treatment of PCOS and shows 
steady effect with minimal side effects. Herbal drugs enhance immunity of the body 
also regularize menstrual cycle without fluctuating hormonal level.  In conclusion 
Hydroalcoholic extract of Grape skin extract shows significant recovery of FSH,LH, 
estradiol & progesterone and also restored the irregular cycle and ovarian physiology 
to normal in the PCOS animals. ThusGrape skin extract was effective in reversing the 
hormonal imbalance induced by estradiol valerate in PCOS & validate the use in 
treatment of infertility. 
 
 
 
 
